BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1747 related articles for article (PubMed ID: 27072307)

  • 1. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
    Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty Assessment in Advanced Heart Failure.
    Madan SA; Fida N; Barman P; Sims D; Shin J; Verghese J; Piña I; Jorde U; Patel SR
    J Card Fail; 2016 Oct; 22(10):840-4. PubMed ID: 26883168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.
    Rodríguez-Pascual C; Paredes-Galán E; Ferrero-Martínez AI; Gonzalez-Guerrero JL; Hornillos-Calvo M; Menendez-Colino R; Torres-Torres I; Vilches-Moraga A; Galán MC; Suarez-Garcia F; Olcoz-Chiva MT; Rodríguez-Artalejo F
    Int J Cardiol; 2017 Jun; 236():296-303. PubMed ID: 28215465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence and Prognostic Significance of Frailty in Patients With Advanced Heart Failure Referred for Heart Transplantation.
    Jha SR; Hannu MK; Chang S; Montgomery E; Harkess M; Wilhelm K; Hayward CS; Jabbour A; Spratt PM; Newton P; Davidson PM; Macdonald PS
    Transplantation; 2016 Feb; 100(2):429-36. PubMed ID: 26516676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
    Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
    BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction.
    Pérez-Calvo JI; Morales-Rull JL; Gimeno-Orna JA; Lasierra-Díaz P; Josa-Laorden C; Puente-Lanzarote JJ; Bettencourt P; Pascual-Figal DA
    Am J Cardiol; 2016 Aug; 118(4):543-9. PubMed ID: 27338207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive variables for mortality in elderly patients hospitalized due to heart failure with preserved ejection fraction].
    Carrasco-Sánchez FJ; Páez-Rubio MI; García-Moreno JM; Vázquez-García I; Araujo-Sanabria J; Pujo-de la Llave E
    Med Clin (Barc); 2013 Nov; 141(10):423-9. PubMed ID: 23790575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Value of Objective Frailty Assessment to Predict Mortality in Elderly Patients Hospitalized for Heart Failure.
    Tanaka S; Kamiya K; Hamazaki N; Matsuzawa R; Nozaki K; Maekawa E; Noda C; Yamaoka-Tojo M; Matsunaga A; Masuda T; Ako J
    J Card Fail; 2018 Nov; 24(11):723-732. PubMed ID: 30010026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
    JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frailty, hospitalization, and progression of disability in a cohort of disabled older women.
    Boyd CM; Xue QL; Simpson CF; Guralnik JM; Fried LP
    Am J Med; 2005 Nov; 118(11):1225-31. PubMed ID: 16271906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.
    Vidán MT; Sánchez E; Fernández-Avilés F; Serra-Rexach JA; Ortiz J; Bueno H
    Clin Cardiol; 2014 Dec; 37(12):725-32. PubMed ID: 25516357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
    Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
    Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2021 Aug; 8(4):2876-2888. PubMed ID: 34080791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases.
    Sánchez E; Vidán MT; Serra JA; Fernández-Avilés F; Bueno H
    Heart; 2011 Oct; 97(19):1602-6. PubMed ID: 21795299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.